Results 1 to 10 of about 39,808 (354)

Preoperative Use of Antiemetics [PDF]

Anesthesiology, 1960
Arthur S. Keats
openalex   +4 more sources

Management of chemotherapy induced emesis [PDF]

Archive of Oncology, 2004
Important progress has been achieved in the last few years in the prevention of chemotherapy-induced nausea and vomiting thanks to the introduction in clinical practice first of the 5-HT3 antagonists and of the NK1 antagonists more recently.
Roila Fausto
doaj   +3 more sources

Pooled analysis of combination antiemetic therapy for chemotherapy-induced nausea and vomiting in patients with colorectal cancer treated with oxaliplatin-based chemotherapy of moderate emetic risk

BMC Cancer, 2021
Background Among patients with colorectal cancer (CRC) treated with oxaliplatin (L-OHP)-based chemotherapy, delayed chemotherapy-induced nausea and vomiting (CINV) have not been well controlled.
Mototsugu Shimokawa, Toshinobu Hayashi, Junichi Nishimura, Taroh Satoh, Mutsumi Fukunaga, Reiko Matsui, Yasushi Tsuji, Fumitaka Mizuki, Takahiro Kogawa   +8 more
doaj   +1 more source

Payer-Imposed Quantity Limits for Antiemetics: Everybody Hurts.

JCO Oncology Practice, 2021
Antiemetics represent one of the greatest advances in modern oncology; perhaps no other intervention has improved the quality of life of people receiving anticancer therapy more than antiemetics.
W. Haque, Ramy Sedhom, F. Chino, T. Royce, Arjun Gupta   +4 more
semanticscholar   +1 more source

The Balance Between the Effectiveness and Safety for Chemotherapy-Induced Nausea and Vomiting of Different Doses of Olanzapine (10 mg Versus 5 mg): A Systematic Review and Meta-Analysis

Frontiers in Oncology, 2021
IntroductionThe aim of this study is to rigorously review the efficacy and safety of olanzapine in chemotherapy-induced nausea and vomiting (CINV) settings including (1) at 5- and 10-mg doses, and (2) the setting of highly emetogenic chemotherapy (HEC ...
Dong-Yang Wang, Yi Chen, You Zhang, Ying-Qiang Shen   +3 more
doaj   +1 more source

Efficacy of Olanzapine for High and Moderate Emetogenic Chemotherapy in Children

Children, 2020
This study was conducted to investigate the safety and efficacy of olanzapine for high and moderate emetogenic chemotherapy in children and young adults.
So Rae Lee, Su Min Kim, Min Young Oh, Jae Min Lee   +3 more
doaj   +1 more source

Prophylaxis of postoperative nausea and vomiting with combination of ondansetron and dexametasone in urology: Prophylaxis of postoperative nausea and vomiting [PDF]

Serbian Journal of Anesthesia and Intensive Therapy, 2016
Introduction: Postoperative nausea and vomiting is an unpleasant, distressing and exhausting experience for patients. There are inconsistent findings concerning approach to the management of PONV and disagreement as to whether prophylaxis of PONV should ...
Gvozdić Branka, Jovičić Jelena, Lađević Nebojša   +2 more
doaj   +1 more source

Antiemetics in Children With Acute Gastroenteritis: A Meta-analysis

Pediatrics, 2020
In this systematic review and NMA, we summarize the evidence supporting the use of ondansetron for achieving cessation of vomiting and reducing hospitalizations. CONTEXT: Several antiemetics have been used in children with acute gastroenteritis. However,
L. Niño-Serna, J. Acosta-Reyes, A. Veroniki, I. Flórez   +3 more
semanticscholar   +1 more source

Expert Consensus on Effective Management of Chemotherapy-Induced Nausea and Vomiting: An Indian Perspective

Frontiers in Oncology, 2020
Chemotherapy-induced nausea and vomiting (CINV) is one of the most common and feared side effects in cancer patients undergoing chemotherapy. Scientific evidence proves its detrimental impact on a patient's quality of life (QoL), treatment compliance ...
Ashok K. Vaid, Sudeep Gupta, Dinesh C. Doval, Shyam Agarwal, Shona Nag, Poonam Patil, Chanchal Goswami, Vikas Ostwal, Sagar Bhagat, Saiprasad Patil, Hanmant Barkate   +10 more
doaj   +1 more source

Oliceridine is Associated with Reduced Risk of Vomiting and Need for Rescue Antiemetics Compared to Morphine: Exploratory Analysis from Two Phase 3 Randomized Placebo and Active Controlled Trials

Pain and Therapy, 2020
Use of parenteral opioids is a major risk factor for postoperative nausea and vomiting. Conventional opioids bind to µ-opioid receptors (MOR), stimulate both the G-protein signaling (achieving analgesia); and the β-arrestin pathway (associated with ...
T. Beard, Cathy Michalsky, K. Candiotti, P. Rider, L. Wase, A. Habib, M. Demitrack, M. Fossler, E. Viscusi   +8 more
semanticscholar   +1 more source